Binding Site specialises in the research, development and manufacture of innovative, high quality, immunodiagnostic assays in the fields of autoimmune disease, multiple myeloma (and other B cell disorders) and investigation of the immune response. The
FreeliteTM assay is the first nephelometric test for measuring free immunoglobin light chains in serum. This is a major breakthrough for the detection and monitoring of Multiple Myeloma (MM) and other B-cell dyscrasia. The Freelite assay gives increased sensitivity and accessibility, providing significant improvements in laboratory and clinical practice for the detection and monitoring of B-cell malignancies.
The Binding Site product portfolio covers the following areas:
- FreeliteTM
- HevyliteTM
- Human IgG and IgA Subclasses
- Nephelometry
- Radial Immunodiffusion
- Serum Protein Electrophoresis
